Literature DB >> 23649439

Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Anthony J Alberg1, Malcolm V Brock2, Jean G Ford3, Jonathan M Samet4, Simon D Spivack5.   

Abstract

BACKGROUND: Ever since a lung cancer epidemic emerged in the mid-1900 s, the epidemiology of lung cancer has been intensively investigated to characterize its causes and patterns of occurrence. This report summarizes the key findings of this research.
METHODS: A detailed literature search provided the basis for a narrative review, identifying and summarizing key reports on population patterns and factors that affect lung cancer risk.
RESULTS: Established environmental risk factors for lung cancer include smoking cigarettes and other tobacco products and exposure to secondhand tobacco smoke, occupational lung carcinogens, radiation, and indoor and outdoor air pollution. Cigarette smoking is the predominant cause of lung cancer and the leading worldwide cause of cancer death. Smoking prevalence in developing nations has increased, starting new lung cancer epidemics in these nations. A positive family history and acquired lung disease are examples of host factors that are clinically useful risk indicators. Risk prediction models based on lung cancer risk factors have been developed, but further refinement is needed to provide clinically useful risk stratification. Promising biomarkers of lung cancer risk and early detection have been identified, but none are ready for broad clinical application.
CONCLUSIONS: Almost all lung cancer deaths are caused by cigarette smoking, underscoring the need for ongoing efforts at tobacco control throughout the world. Further research is needed into the reasons underlying lung cancer disparities, the causes of lung cancer in never smokers, the potential role of HIV in lung carcinogenesis, and the development of biomarkers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23649439      PMCID: PMC4694610          DOI: 10.1378/chest.12-2345

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  359 in total

Review 1.  The molecular epidemiology of asbestos and tobacco in lung cancer.

Authors:  Heather H Nelson; Karl T Kelsey
Journal:  Oncogene       Date:  2002-10-21       Impact factor: 9.867

2.  Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics.

Authors:  Anders Nordström; Elizabeth Want; Trent Northen; Janne Lehtiö; Gary Siuzdak
Journal:  Anal Chem       Date:  2007-12-18       Impact factor: 6.986

3.  Immune deficiency and risk for malignancy among persons with AIDS.

Authors:  Sam M Mbulaiteye; Robert J Biggar; James J Goedert; Eric A Engels
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

Review 4.  Does interstitial lung disease predispose to lung cancer?

Authors:  Craig E Daniels; James R Jett
Journal:  Curr Opin Pulm Med       Date:  2005-09       Impact factor: 3.155

5.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

6.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

Authors:  C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

7.  Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.

Authors:  Phouthone Keohavong; Wei-Min Gao; Kui-Cheng Zheng; Hussam Mady; Qing Lan; Mona Melhem; Judy Mumford
Journal:  Anal Biochem       Date:  2004-01-01       Impact factor: 3.365

8.  Mentholated cigarette use and lung cancer.

Authors:  S Sidney; I S Tekawa; G D Friedman; M C Sadler; D P Tashkin
Journal:  Arch Intern Med       Date:  1995-04-10

9.  Multivitamins, folate, and green vegetables protect against gene promoter methylation in the aerodigestive tract of smokers.

Authors:  Christine A Stidley; Maria A Picchi; Shuguang Leng; Randy Willink; Richard E Crowell; Kristina G Flores; Huining Kang; Tim Byers; Frank D Gilliland; Steven A Belinsky
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

10.  Lung cancer detection by a RT-nested PCR using MAGE A1--6 common primers.

Authors:  Sanghoon Jheon; Dae-Sung Hyun; Sang-Chae Lee; Ghil-Suk Yoon; Chang-Ho Jeon; Jong-Wook Park; Chang-Kwon Park; Man-Hong Jung; Kang-Dae Lee; Hee-Kyung Chang
Journal:  Lung Cancer       Date:  2004-01       Impact factor: 5.705

View more
  219 in total

1.  Comments on characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Authors:  Orazio Schillaci; Ferdinando F Calabria
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

2.  Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study.

Authors:  S Vatrano; L Righi; T Vavalá; I Rapa; M Busso; S Izzo; S Cappia; A Veltri; M Papotti; G V Scagliotti; S Novello
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

Review 3.  The role of the immune system in non-small cell lung carcinoma and potential for therapeutic intervention.

Authors:  Joanna Domagala-Kulawik
Journal:  Transl Lung Cancer Res       Date:  2015-04

4.  Enhancement of tumor suppressor RAR-β protein expression by cationic liposomal-ATRA treatment in benzo(a)pyrene-induced lung cancer mice model.

Authors:  S Viswanathan; V M Berlin Grace; J Perinba Danisha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-12-12       Impact factor: 3.000

Review 5.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

6.  Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.

Authors:  Claudia Stumpf; Daniel Kaemmerer; Elisa Neubauer; Jörg Sänger; Stefan Schulz; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

7.  The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.

Authors:  Busra Gul; Selma Metintas; Guntulu Ak; Senay Yilmaz; Muzaffer Metintas
Journal:  Support Care Cancer       Date:  2020-10-30       Impact factor: 3.603

Review 8.  Risk factors assessment and risk prediction models in lung cancer screening candidates.

Authors:  Mariusz Adamek; Ewa Wachuła; Sylwia Szabłowska-Siwik; Agnieszka Boratyn-Nowicka; Damian Czyżewski
Journal:  Ann Transl Med       Date:  2016-04

9.  Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.

Authors:  Cigdem Usul Afsar; Berksoy Sahin; Meral Gunaldi; Emine Kılıc Bagir; Derya Gumurdulu; Refik Burgut; Melek Erkisi; Ismail Oguz Kara; Semra Paydas; Feryal Karaca; Vehbi Ercolak
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

10.  Tankyrase 1 polymorphism associated with an increased risk in developing non-small cell lung cancer in a Chinese population: a proof-of-principle study.

Authors:  Ying Wang; Weiyu Jiang; Xiaogu Liu; Yongjun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.